One-year follow-up of patients treated with single antiplatelet therapy directly after percutaneous coronary intervention for non-ST-segment elevation acute coronary syndrome

Niels M R van der Sangen; Bimmer E P M Claessen; I Tarik Küçük; Alexander W den Hartog; Wouter J Kikkert; Yolande Appelman; José P S Henriques

doi:10.1093/ehjopen/oead075

One-year follow-up of patients treated with single antiplatelet therapy directly after percutaneous coronary intervention for non-ST-segment elevation acute coronary syndrome

Eur Heart J Open. 2023 Aug 9;3(5):oead075. doi: 10.1093/ehjopen/oead075. eCollection 2023 Sep.

Authors

Niels M R van der Sangen¹, Bimmer E P M Claessen¹, I Tarik Küçük¹, Alexander W den Hartog¹, Wouter J Kikkert^{1

2}, Yolande Appelman³, José P S Henriques¹

Affiliations

¹ Department of Cardiology, Amsterdam UMC, University of Amsterdam, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands.
² Department of Cardiology, Tergooi Hospital, Hilversum, The Netherlands.
³ Department of Cardiology, Amsterdam UMC, VU University, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands.

Abstract

Graphical AbstractClinical outcomes and treatment adherence during 12 months follow-up. *Second bleeding event in same patient. PCI, percutaneous coronary intervention; TVR, target vessel revascularization.